The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer by Viacheslav Soyfer et al.
Soyfer et al. Radiation Oncology 2014, 9:81
http://www.ro-journal.com/content/9/1/81RESEARCH Open AccessThe impact of overall radiotherapy treatment time
and delay in initiation of radiotherapy on local
control and distant metastases in gastric cancer
Viacheslav Soyfer*, Ravit Geva, Michael Michelson, Moshe Inbar, Einat Shacham-Shmueli and Benjamin W CornAbstract
Objectives: To study the impact of time factors on local and distant metastases in stomach cancer.
Methods: 67 patients with gastric cancer who received adjuvant treatment were reviewed for the time to initiation
of radiotherapy, overall duration of RT and the events of first local recurrence or distant metastasis.
Results: The risk probability of local recurrence is increased by 10% (HR = 1.1, p = 0.0009) in association with each
additional day of radiotherapy and by 3.8% (HR = 1.038, p = 0.13) per increased day of waiting time before the
initiation of RT. The risk probability of distant recurrence was associated with an increase of 7.4% (HR = 1.074
p = 0.0031) with each additional day of RT time and by 2.3% (HR = 1.023, p = 0.0598) following the increase of a day of
waiting time. Each day of prolongation of RT beyond 36 days was associated with an increased risk of local recurrence
by 10% (OR = 1.1, p = 0.015). Prolongation of waiting time prior to initiation of irradiation retained significance in
multivariate analysis.
Conclusion: There is an association between total treatment time and, to some extent, the time between the surgery
and the initiation of radiation on local control and distant metastases.
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The effect of prolonged overall treatment time of radiation
therapy as well as the impact of delaying the initiation of
radiation treatment have been extensively discussed in the
literature [1-7]. In general, it is thought that accelerated
repopulation of the tumor cells during these protracted
intervals is responsible for the inferior results of the
treatment [1]. Increased local failures were detected after a
prolonged course of radiotherapy in head and neck malig-
nancies, lung cancer and bladder cancer [4,8,9]. We
sought to describe the relationship between the interval
before the initiation of radiation and overall radiotherapy
time upon local control and distant metastases.Methods
Sixty-seven patients with primary gastric cancer were
treated with adjuvant chemoradiation after curative surgery
in 2003–2008 according to the protocol guidelines of* Correspondence: slavas2506@yahoo.com
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unless otherwise stated.INT0116 [10]. There were 31 women and 36 men. Median
age was 59.8 (range 18–79) years. Patient characteristics
are presented in Table 1. Median follow up was 60 months.
Complete data were available on 49 patients. A total of
sixty-six patients completed the prescribed adjuvant
treatment between the years 2003 and 2008. One patient
did not wish to continue radiation therapy after two frac-
tions and declined to give a reason for his decision.
Chemotherapy was administered in compliance with the
regimen specified in INT-0116 with insufficient deviation
to cause concern for confounding of our conclusions.
The mean treatment time was 37 days (range 8–80) SD
10.8 days). The mean time to initiation of RT was 93.8 days
(SD24.5). The total radiation treatment time and the inter-
val from surgery to the initiation of radiation were each
correlated with the rate of local recurrence and distant
metastases. The secondary goal of the study was to
characterize the relationship between the time to appear-
ance of the first local or distant metastasis as a function oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Patient and tumor characteristics (N = 67)





















N0-1 (0–6) 39 58
N2 (7–15) 12 18
N3 (>15) 7 10
Unknown 9 14
Table 2 Local recurrence (Cox regression analysis)
Parameter P value Hazard ratio 95% hazard ratio
confidence limits
Duration of RT days 0.0009 1.101 1.040 1.165
Waiting time 0.1341 1.038 0.989 1.090
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Regression analysis of survival data based on the Cox
proportional hazards model was used to explain the effect
of time to the initiation of RT and overall RT time on local
and distant recurrence hazard rates. The patients were
grouped in days of RT or days to the initiation of RT in
accordance with their proportional representation in
the study population. The distribution of overall treat-
ment time was as follows: less than 36 days (57.1%) and
greater than or equal to 36 days (42.9%). Regarding the
time to initiation of RT the distribution was as follows:
less than or equal to 76 days (first 25%), 76-107(50%)
and above 107 days (upper 25% of population). Logistic
regression analysis was applied to reveal the odds ratio
of local recurrence and distant metastases as a function
of time to initiation of treatment and overall radiother-
apy time.
We also applied Cox regression analysis to reveal the
possible interaction between the observed results of tim-
ing and recurrence with other co factors: age, number of
involved lymph nodes and stage of the disease.Approval was obtained from the institutional review
board of Tel Aviv Medical Center to carry out this analysis.
Results
Documentation of relative intervals
For the five patients who experienced local recurrence
and the 44 who did not, the median total radiotherapy
treatment time was 52.6 days, (range, 32–80; SD 24.7) and
34.8 days (range 31–56 SD 5 days), respectively (HR 1.09,
95% CI p- 0.01). With regards to the same comparative
sub-groups, the time from surgery to initiation of radiation
therapy was 108.3 days (range 88–142; SD 29.4) versus
88.4 days, (range 24–146; SD 23.3), respectively (HR 1.04,
95% CI p- 0.134).
Impact on distant failure
For the 19 patients who experienced distant metastases
and the 30 individuals who did not, the total radiotherapy
time was 38.1 days (range 31–80; SD 12.4) versus 35.6 days
(range 32–79; SD 8.6), respectively (HR 1.07, p- 0.003).
With respect to the same comparative sub-groups, the
time from surgery to the initiation of radiation therapy
was 93.8 days (SD 23.6) versus 87 days (SD 24.1), respect-
ively (HR 1.02, p- 0.059).
Impact on local recurrence
Cox regression analysis showed that each additional day
that the course of irradiation was extended beyond the
projected time, was associated with an increased risk
probability of local recurrence by 10% (HR = 1.1 (1.04-
1.016), p =0.0009). An increase of a day in the duration
between surgery and the initiation of radiation was as-
sociated with an increased (albeit non-significantly) risk
probability of local recurrence by 3.8% (HR = 1.038
(0.989-1.09), p = 0.13) (Table 2, Figure 1).
The risk probability of distant recurrence in the next
period is associated with an increase of 7.4% (HR = 1.074
(1.0124-1.125), p = 0.0031) for every day that the delivery
of RT is extended (Figure 2) and associated with an in-
crease of 2.3% (HR = 1.023 (0.999-1.048), p = 0.0598) for
each day that the duration between surgery and initiation
of RT is prolonged (Table 3, Figure 2).
Using logistic regression analysis, we detected a statisti-
cally significant increased odds ratio in local recurrence as
a function of overall treatment time. Specifically, every day
of prolongation of radiotherapy beyond 36 days was asso-
ciated with an increased risk of local recurrence by 10%
Figure 1 Kaplan Meier curves of time to local recurrence
(comparison of 3 groups of time to treatment).
Table 3 Distant metastases (Cox regression analysis)
Parameter P value Hazard ratio 95% hazard ratio
confidence limits
Duration of RT days 0.0031 1.074 1.024 1.125
Waiting Time 0.0598 1.023 0.999 1.048
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as a function of waiting time was 10% (p = 0.035).
In logistic regression analysis there was no statistically
significant correlation between the waiting time and rate of
local recurrence (OR- 1,037, p = 0.169) and the overall RT
time and rate of distant metastases (OR- 1.024, p = 0.42).
Age, number of lymph nodes (grouped to 3 categories
according to nodule staging of TNM) and stage itself do
not affect the HR of local recurrence (p = 0.54, 0.99, 0.83
respectively).
It appears that age does not influence the HR of distant
metastases (HR 0.99, p = 0.83).
Univariate analysis of the influence of the number of
involved lymph nodes and stage on the rate of distant
metastases showed the interesting observations. N3 stage
(15 or more lymph nodes) compared with lesser nodule
stage is linked with HR of 7.2 (p = 0.0011) in association
with waiting time to initiation of radiation therapy. StageFigure 2 Kaplan Meier curves of time to distant metastases
(comparison of 3 groups of time to treatment).3 of the disease compared with one and two in association
with overall treatment time seems to increase the risk of
distant metastases (HR = 2.7, p = 0.056).
On multivariate analysis the effect of the overall treat-
ment time and waiting time to initiation of radiation
therapy remains strong after adjusting to the number
of the involved lymph nodes and stage of the disease
(HR = 1.09, p = 00006 and HR = 1.034, p = 0.004, respect-
ively) (Table 4).
Discussion
In recent years, two standards have emerged in the adju-
vant management of gastric cancer. Cunningham et al.
reported that a pre-operative regimen of Epirubicin,
Cisplatin and 5-Fluoruracil improves outcome in com-
parison to patients managed with surgery alone [11].
The results of the INT 0116 study showed that median
overall survival for gastric cancer patients in the surgery-
only group was 27 months, as compared with 36 months
in the chemoradiotherapy group [10]. Smalley et al. recently
published 10-year follow up for living patients participating
in the INT 0116 study. Overall survival and RFS continue
to demonstrate dramatic benefit for patients who received
adjuvant radiochemotherapy. Hazard ratios remains virtu-
ally unchanged from the initial report [12]. In the original
report of INT 0116 there was no mention of prolonged
overall treatment time that was attributable to toxicity. We
are aware of no published secondary analyses of INT 0116
that describe the impact of temporal factors upon outcome.
In fact, despite the recent trend to study the impact of such
factors upon outcomes of radiation treatment for a range
of malignancies, we were unable to identify any primary
papers (in a comprehensive search of databases from
PubMed, EMBASE, MEDLINE, and the Cochrane Data-
base) that assessed this parameter for adenocarcinoma of
the stomach.
In most radiobiological models [1] it is axiomatic that
protracting the course of radiation increases clonogen
regeneration in human tumors. The effect of the overall
treatment time on local control and distant metastases
had been well-studied in several malignant diseases that
require irradiation as the primary modality [3,4,8].
The phenomenon of delays in initiating radiation treat-
ment has also been widely discussed. Wyatt RM et al.
showed that delays in the initiation of radiotherapy
decrease tumor control for head and neck as well as
breast cancers. Pursuant to surgery, the growth rates
Table 4 Univariate and multivariate analysis of risk factors for local recurrence and distant metastases
HR of risk factors for LR and DM (univariate cox regression analysis)
Factor HR for LR (95% CI) HR for DM (95% CI)
Time to treatment (Days) 1.038 (0.99, 1.09) 1.023 (1.0,1.04)
Age at diagnosis 0.98 (0.91, 1.05) 0.996 )0.96,1.04)
LN group (3 vs (1 + 2)) 1 (0,0) 7.183 (2.2,23.4)
Stage (3 vs 1 + 2) 1.081 (0.11,10.40) 2.703 (0.97,7.5)
Overall treatment time (Days) 1.101 (1.04,1.17) 1.074 (1.02,1.13)
Multivariate analysis of risk factors for DM
Factor HR (95% CI) Factor HR (95% CI)
Overall treatment time (Days) 1.090 (1.04,1.14) Time to treatment (Days) 1.03 (1.00,1.07)
LN group (3 vs (1 + 2)) 5.093 (1.12,23.25) LN group (3 vs (1 + 2)) 5.17 (1.12,23.92)
Stage (3 vs 1 + 2) 1.72 (0.43,6.94) Stage (3 vs 1 + 2) 1.14 (0.29,4.43)
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high proportion of oxic cells and a reduced cell loss
factor. In head and neck tumors, there may be a reduction
in local tumor control of up to 1.5% per week’s delay
following surgery. Similarly, for breast cancers treated
following surgery, there may be a reduction in tumor
control of between 0.3% and 1.4% per week’s delay [5].
Do et al. [13] described a 2% decrease in overall survival
per day associated with delays in the initiation of radiation
treatment for glioblastoma multiforme. Fortin [14] noted
a decrease in survival of patients with early-stage head-
and-neck cancer if RT was initiated 40 days after the diag-
nosis. Longer radiotherapy waiting times were found to be
associated with diminished survival outcomes for patients
treated with definitive radiotherapy for cervix cancer [15].
In contrast, there is evidence that the length of the
period prior to the initiation of irradiation does not sig-
nificantly impair the results of treatment. For instance,
Barton et al. concluded, after performing a multivariate
analysis of factors pertaining to 581 patients, that waiting
time for radiotherapy for early larynx cancer is not associ-
ated with increased local recurrence [7]. Similarly, Brouha
et al. did not find a correlation between waiting time and
the outcome of early glottic cancer [8].
Blumenthal and colleagues presented counter-intuitive
findings implying a direct correlation between survival
and prolongation of the interval between surgery and ini-
tiation of irradiation. This anomaly was attributed to in-
sufficient time for recovery following surgically-induced
brain trauma [2].
The results of our study showed an association between
total treatment time and, to some extent, the time be-
tween the surgery and radiation on local control and
distant metastases. Modern radiotherapy techniques
(e.g., IMRT, IGRT) are designed to optimize dose depos-
ition within the target and to simultaneously spare adjacent
normal tissues. Such technologies may have a favorable
impact on not only chronic but also acute symptoms. Ifindeed radiotherapy is tolerated with a minimum of acute
morbidity, then it is likely that overall treatment time will
not be prolonged thereby improving local and distant
control of disease. It must be acknowledged that one of
the limitations in such a retrospective analysis could be
the fact that patients who were “sicker” suffered more
acute morbidity and that the decrements in local and
distant control were actually a function of their inherent
illness as opposed to an outgrowth of temporal delays in
radiation delivery.
We also observed a correlation between the time from
the surgery to the initiation of radiation therapy and the
rate of distant metastases (HR 1.02, p- 0.059), that is
extremely prominent in patients with locally advanced
disease. This finding seems to offer an impetus to shorten
the post-op interval prior to initiating adjuvant irradiation.
Issues related to the impact of patient recovery following
surgery are beyond the scope of this report.
There are, of course, multiple limitations of this retro-
spective study of a relatively small number of patients
and accordingly, the findings are more exploratory than
conclusive. Multivariate analysis of the impact of different
co-variants on the endpoints of local control, freedom
from distant metastases and even overall survival among
gastric cancer patients is wanting in the scientific litera-
ture. Nevertheless physicians should be cognizant of
the potential influence of the temporal factors discussed
and therefore are advised to redouble efforts to maximize
efficiencies in delivering treatment without unnecessary
delays and interruptions.
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